Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Version 1
Inhibitory effect of Astragalus Polysaccharide combined with cisplatin on cell cycle and migration of nasopharyngeal carcinoma cell lines
Ya li YangZhan wen LinPei ting HeHua NieQian yin YaoSheng yuan Zhang
Author information
JOURNALS FREE ACCESS Advance online publication

Article ID: b20-00959


Background Astragalus Polysaccharide (APS) had shown great promise in anti-tumour activities in our previous studies. The present study was designed to investigate whether APS has synergistic effect with cisplatin on the growth-inhibitory of human nasopharyngeal carcinoma cell lines and the possible mechanism. Methods Here, nasopharyngeal carcinoma cell lines (CNE-1) were divided into CNE-1 group, Cisplatin treatment group (2 μg/ml Cisplatin), APS treatment group (200 μg/ml APS) and combination group (2 μg/ml Cisplatin and 200 μg/ml APS). The proliferation inhibition rate of CNE-1 cells was determined by CCK-8 method after treatment with different concentrations of APS for 24, 48, and 72 h. Apoptosis rates and cell cycle retardation of cells were detected by flow cytometry. Cell migration and invasion was evaluated by transwell assay. Western blotting and qRT-PCR were performed to detect the expression of Bcl-2, Bax, Caspase-3, matrix metalloproteinase-2(MMP-2), p53 and matrix metalloproteinase-9(MMP-9) proteins in CNE-1 cells. Results APS have an inhibition on the proliferation of CNE-1 cells with time and dose dependence manner. Both the APS and combination therapy could promote apoptosis of CNE-1 cells, with the count of cells increased in G0/G1 and S phase while decreased in G2/M phase, and inhibited the migration and invasion of CNE-1 cells. Moreover, co-administration of Cisplatin and APS was more efficacious for the antitumor effect than either agent alone, as evidenced by the significant decrease in MMP-9 level and increase in p53. Conclusion APS, in combination with cisplatin, had significantly synergistic growth-inhibitory effect on nasopharyngeal carcinoma cell lines, which may be related to cell cycle and migration induction.

Information related to the author
© 2021 The Pharmaceutical Society of Japan
Previous article Next article